TNX-832 (Sunol cH36)

TNX-832 · Altor BioScience

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TNX-832 (Sunol cH36), covering 2025-01-06 to 2025-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome [Phase 1]